Back
Northern Oil & Gas Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
80
NOG
Northern Oil & Gas
Last Price:
40.96
Seasonality Move:
16.53%
Sell
50
BMRN
Biomarin Pharmaceutical
Last Price:
67.07
Seasonality Move:
13.3%
Buy
80
Northern Oil & Gas (NOG)
is a Buy
Is Northern Oil & Gas a Buy, Sell or Hold?
- The current Northern Oil & Gas [NOG] share price is $40.54. The Score for NOG is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- NOG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.94. The Score for BMRN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NOG Stock Price Chart
What is Northern Oil & Gas's stock price today?
-
The Northern Oil & Gas share price today is $40.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NOG is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
NOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 64.91 | Buy |
| Chaikin Money Flow: | -1037364 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.52 - 39.58) | Buy |
| Bollinger Bands (100): | (36.15 - 39.95) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 36.09 | Sell |
| Chaikin Money Flow: | 719480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.18 - 70.54) | Sell |
| Bollinger Bands (100): | (71.12 - 88.28) | Sell |
NOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.39 | Buy |
| 20-day SMA: | 37.7 | Buy |
| 50-day SMA: | 37.18 | Buy |
| 200-day SMA: | 38.13 | Buy |
| 8-day EMA: | 38.22 | Buy |
| 20-day EMA: | 37.69 | Buy |
| 50-day EMA: | 37.65 | Buy |
| 200-day EMA: | 35.78 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.77 | Buy |
| 20-day SMA: | 68.82 | Sell |
| 50-day SMA: | 73.61 | Sell |
| 200-day SMA: | 82.44 | Sell |
| 8-day EMA: | 67.01 | Sell |
| 20-day EMA: | 68.55 | Sell |
| 50-day EMA: | 72.74 | Sell |
| 200-day EMA: | 81.12 | Sell |
Northern Oil & Gas Earnings Growth & NOG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.35 per share, and a decrease next year of $0.11 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Northern Oil & Gas Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||